177 related articles for article (PubMed ID: 23856826)
1. Thyroid lymphoma incidentally detected by 18F-fluorocholine (FCH) PET/CT.
Eccles A; Challapalli A; Khan S; Barwick T; Mangar S
Clin Nucl Med; 2013 Sep; 38(9):755-7. PubMed ID: 23856826
[TBL] [Abstract][Full Text] [Related]
2. Oncocytic Adenoma of Thyroid Incidentally Detected by 18F-Fluorocholine PET/CT.
Aziz AL; Courbon F; Dierickx LO; Pascal P; Zerdoud S
J Nucl Med Technol; 2015 Jun; 43(2):133-4. PubMed ID: 25857420
[TBL] [Abstract][Full Text] [Related]
3. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
[TBL] [Abstract][Full Text] [Related]
4. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
5. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
Beheshti M; Haim S; Zakavi R; Steinmair M; Waldenberger P; Kunit T; Nader M; Langsteger W; Loidl W
J Nucl Med; 2013 Jun; 54(6):833-40. PubMed ID: 23559588
[TBL] [Abstract][Full Text] [Related]
6. Metastatic prostate cancer proven by 18F-FCH PET/CT staging scan in patient with normal PSA but high PSA doubling time.
Hodolič M; Maffione AM; Fettich J; Gubina B; Cimitan M; Rubello D
Clin Nucl Med; 2013 Sep; 38(9):739-40. PubMed ID: 23816948
[TBL] [Abstract][Full Text] [Related]
7. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
[TBL] [Abstract][Full Text] [Related]
8. Incidental possible diagnosis by 18F-fluorocholine PET/CT of Meckel's diverticulum and potential pitfalls.
Khor LK; Loi HY; Sinha AK; Lu SJ
Hell J Nucl Med; 2015; 18(2):157-9. PubMed ID: 26187217
[TBL] [Abstract][Full Text] [Related]
9. A thyroid incidentaloma detected by 18F-choline PET/CT.
Treglia G; Giovannini E; Mirk P; Di Franco D; Oragano L; Bertagna F
Clin Nucl Med; 2014 Apr; 39(4):e267-9. PubMed ID: 23579984
[TBL] [Abstract][Full Text] [Related]
10. Incidental detection of Hürthle cell adenoma by 18F-choline PET/CT scan in a patient with prostate cancer.
Paone G; Treglia G; Bongiovanni M; Ruberto T; Ceriani L; Giovanella L
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):340-1. PubMed ID: 23796426
[No Abstract] [Full Text] [Related]
11. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.
Beheshti M; Imamovic L; Broinger G; Vali R; Waldenberger P; Stoiber F; Nader M; Gruy B; Janetschek G; Langsteger W
Radiology; 2010 Mar; 254(3):925-33. PubMed ID: 20177103
[TBL] [Abstract][Full Text] [Related]
12. Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer disease.
Cimitan M; Hodolič M; Maffione AM; Borsatti E; Urso C; Colletti PM; Rubello D
Clin Nucl Med; 2013 Sep; 38(9):752-4. PubMed ID: 23856823
[TBL] [Abstract][Full Text] [Related]
13. Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET/CT.
Pinaquy JB; Allard JB; Cornelis F; Pasticier G; De Clermont H
Clin Nucl Med; 2015 Apr; 40(4):e255-7. PubMed ID: 25674860
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer localization with 18fluorine fluorocholine positron emission tomography.
Kwee SA; Coel MN; Lim J; Ko JP
J Urol; 2005 Jan; 173(1):252-5. PubMed ID: 15592091
[TBL] [Abstract][Full Text] [Related]
15. Incidental Detection of Oxyphilic Papillary Thyroid Carcinoma by 18F-Fluorocholine PET/CT.
Lalire P; Zalzali M; Garbar C; Bruna-Muraille C; Morland D
Clin Nucl Med; 2016 Jun; 41(6):512-3. PubMed ID: 26914574
[TBL] [Abstract][Full Text] [Related]
16. 18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study.
Gillebert Q; Huchet V; Rousseau C; Cochet A; Olivier P; Courbon F; Gontier E; Nataf V; Balogova S; Talbot JN;
PLoS One; 2018; 13(2):e0191487. PubMed ID: 29425221
[TBL] [Abstract][Full Text] [Related]
17. Effect of erythropoietin on bone marrow uptake of 18F-fluorocholine in prostate cancer: comparison with 18F-fluoride uptake.
Balogova S; Huchet V; Egrot C; Michaud L; Paycha F; Kerrou K; Montravers F; Cussenot O; Talbot JN
Clin Nucl Med; 2013 Mar; 38(3):200-2. PubMed ID: 23354033
[TBL] [Abstract][Full Text] [Related]
18. False-positive result in 18F-fluorocholine PET/CT due to incidental and ectopic parathyroid hyperplasia.
Cazaentre T; Clivaz F; Triponez F
Clin Nucl Med; 2014 Jun; 39(6):e328-30. PubMed ID: 24152627
[TBL] [Abstract][Full Text] [Related]
19. Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer.
Beauregard JM; Williams SG; Degrado TR; Roselt P; Hicks RJ
J Med Imaging Radiat Oncol; 2010 Aug; 54(4):325-32. PubMed ID: 20718912
[TBL] [Abstract][Full Text] [Related]
20.
Metser U; Berlin A; Halankar J; Murphy G; Jhaveri KS; Ghai S; Tau N
AJR Am J Roentgenol; 2018 Mar; 210(3):635-640. PubMed ID: 29323548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]